We are live on ! Find out more
GA

General Atlantic Portfolio holdings

AUM $2.15B
1-Year Est. Return 35.02%
This Fund
S&P 500
This Quarter Est. Return
-3.91%
1 Year Est. Return
+35.02%
3 Year Est. Return
+185.68%
5 Year Est. Return
+122.28%
10 Year Est. Return
+1,080.07%
AUM
$2.15B
AUM Growth
-$724M
Cap. Flow
-$587M
Cap. Flow %
-27.33%
Top 10 Hldgs %
99.84%
Holding
13
New
–
Increased
1
Reduced
4
Closed
1

Top Buys

Rank Stock Value
1
ALKT icon
Alkami Technology
ALKT
+$61.6M

Top Sells

Rank Stock Value
1
ALHC icon
Alignment Healthcare
ALHC
+$260M
2
RVMD icon
Revolution Medicines
RVMD
+$213M
3
CNTA
Centessa Pharmaceuticals
CNTA
+$122M
4
XP icon
XP
XP
+$41.2M
5
NRIX icon
Nurix Therapeutics
NRIX
+$13.2M

Sector Composition

Rank Sector Weight
1 Technology 58.87%
2 Healthcare 19.23%
3 Financials 18.23%
4 Consumer Staples 3.67%

No holdings matched the selected filter criteria.

Similar funds

NAAA
New Age Alpha Advisors Rye, New York $2.15B AUM 27.2% 1-Year Est. Return
MA
Montag & Associates Atlanta, Georgia $2.15B AUM 20.86% 1-Year Est. Return
SC
SouthState Corp Winter Haven, Florida $2.14B AUM 18.39% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return
CI
Cambiar Investors Denver, Colorado $2.16B AUM 16.24% 1-Year Est. Return
AAP
Aristotle Atlantic Partners Sarasota, Florida $2.14B AUM 37.01% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return

General Atlantic's Q1 2026 Portfolio in Review

As of Q1 2026, General Atlantic held 13 positions worth $2.15B, down 25% from $2.87B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

General Atlantic withdrew a net $587M in Q1 2026, closing 1 position and reducing 4 holdings. Its most notable exit was Alignment Healthcare, an estimated $260M position sold in full.

By sector, the portfolio is most concentrated in Technology at 59% of assets, up from 52% a quarter earlier, followed by Healthcare and Financials.

Against the trend, General Atlantic added an estimated $61.6M to Alkami Technology.

  • General Atlantic added most to Alkami Technology in Q1 2026, an estimated $61.6M increase.
  • General Atlantic's biggest Q1 2026 reduction was Revolution Medicines, cutting an estimated $213M.
  • General Atlantic fully exited Alignment Healthcare in Q1 2026, selling an estimated $260M.
  • General Atlantic's ten largest holdings make up 100% of its $2.15B portfolio in Q1 2026.
  • General Atlantic opened 0 new positions and closed 1 in Q1 2026.
  • General Atlantic's portfolio value fell 25% quarter-over-quarter to $2.15B.

Based on General Atlantic's 13F filing for Q1 2026, filed 15 May 2026.